SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-18-012360
Filing Date
2018-08-20
Accepted
2018-08-20 16:48:48
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm 10-Q/A 605609
2 ex31-1.htm EX-31.1 19659
3 ex31-2.htm EX-31.2 11771
4 ex32-1.htm EX-32.1 8471
5 ex32-2.htm EX-32.2 8290
  Complete submission text file 0001493152-18-012360.txt   3640372

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20170930.xml EX-101.INS 599134
7 XBRL SCHEMA FILE prph-20170930.xsd EX-101.SCH 44944
8 XBRL CALCULATION FILE prph-20170930_cal.xml EX-101.CAL 58542
9 XBRL DEFINITION FILE prph-20170930_def.xml EX-101.DEF 156397
10 XBRL LABEL FILE prph-20170930_lab.xml EX-101.LAB 324073
11 XBRL PRESENTATION FILE prph-20170930_pre.xml EX-101.PRE 236451
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-21617 | Film No.: 181028678
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1